| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Revenue | $6.85B | +8.4% |
| Cost of Revenue | $3.13B | +7.3% |
| R&D Expense | $467.0M | +5.9% |
| SG&A Expense | $1.64B | +1.1% |
| Operating Income | $1.62B | +20.1% |
| Interest Expense | $84.0M | +3.7% |
| Pre-tax Income | $1.50B | +10.6% |
| Income Tax | $250.0M | +66.7% |
| Net Income | $1.25B |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.05B | -29.0% |
| Accounts Receivable | $1.41B | +19.9% |
| Inventory | $1.04B | +25.1% |
| Current Assets | $3.78B | -0.6% |
| Total Assets | $10.53B | -1.6% |
| Current Liabilities | $1.86B | +9.0% |
| Long-term Debt | $2.73B | +0.1% |
| Line Item | 2022-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.31B | -11.6% |
| Capital Expenditures | $291.0M | +54.8% |
| Investing Cash Flow | -$338.0M | +54.9% |
| Financing Cash Flow | -$1.37B | -97.1% |
| Free Cash Flow | $1.02B | -21.3% |
| +3.6% |
| EPS (Basic) | $4.19 | +5.3% |
| EPS (Diluted) | $4.18 | +6.1% |
| Total Liabilities |
| $5.23B |
| -1.7% |
| Stockholders' Equity | $5.30B | -1.6% |